Are you Dr. Quon?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 39 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000- Is this information wrong?
Summary
- Dr. Andrew Quon, MD is a board certified nuclear medicine physician in Stanford, California. He is currently licensed to practice medicine in California. He is an Assistant Professor at Stanford University Medical Center.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Nuclear Medicine, 2000 - 2002
- Kaiser Permanente Northern California (Oakland)Internship, Internal Medicine, 1998 - 1999
- University of Texas Southwestern Medical SchoolClass of 1998
Certifications & Licensure
- CA State Medical License 1999 - 2025
- American Board of Nuclear Medicine Nuclear Medicine
Clinical Trials
- Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI Start of enrollment: 2007 Oct 01
- FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large B-cell Lymphoma Start of enrollment: 2017 Sep 07
- Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer Start of enrollment: 2012 May 01
Publications & Presentations
PubMed
- In search for optimal induction chemotherapy for advanced nasopharyngeal cancer: Standard dosing of Docetaxel, Platinum, and 5-Fluorouracil (TPF) followed by chemoradi...Michelle Jun, Harlan Pinto, Quynh-Thu Le, Andrew Quon, Wendy Hara, Jessie Coty, Alex McMillan, Rong Lu, Elzbieta Winters, Ruth Lira, A Dimitrios Colevas> ;Plos One. 2023 Jan 1
- 1 citationsDetection of Recurrence After Thoracic Stereotactic Ablative Radiotherapy Using FDG-PET-CT.Quaovi H Sodji, Jeremy P Harris, Andrew Quon, Brianna Lau, Alice Jiang, Nicholas Trakul, Peter G Maxim, Maximilian Diehn, Billy W Loo Jr, Susan M Hiniker, Modlin, L.> ;Clinical Lung Cancer. 2022 May 1
- 3 citations18F-FDG PET/CT imaging biomarkers for early and late evaluation of response to first-line chemotherapy in patients with pancreatic ductal adenocarcinoma.Matthias R. Benz, Wesley R Armstrong, Francesco Ceci, Giulia Polverari, Timothy R. Donahue, Zev A. Wainberg, Andrew Quon, Martin Auerbach, Mark D. Girgis, Ken Herrmann...> ;Journal of Nuclear Medicine. 2021 Jul 16
- Join now to see all
Press Mentions
- Molecular Imaging Pinpoints Source of Chronic Back PainJune 16th, 2011